Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 5
2016 3
2017 1
2019 7
2020 11
2021 4
2022 9
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Calfa CJ, Rothe M, Mangat PK, Garrett-Mayer E, Ahn ER, Burness ML, Gogineni K, Rohatgi N, Al Baghdadi T, Conlin A, Gaba A, Hamid O, Krishnamurthy J, Gavini NJ, Gold PJ, Rodon J, Rueter J, Thota R, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Calfa CJ, et al. Among authors: gogineni k. JCO Precis Oncol. 2024 Feb;8:e2300513. doi: 10.1200/PO.23.00513. JCO Precis Oncol. 2024. PMID: 38354330
Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome.
Miller-Kleinhenz JM, Moubadder L, Beyer KM, Zhou Y, Gaglioti AH, Collin LJ, Gohar J, Do W, Conneely K, Krishnamurti U, Gogineni K, Gabram-Mendola S, D'Angelo O, Henry K, Torres M, McCullough LE. Miller-Kleinhenz JM, et al. Among authors: gogineni k. Front Oncol. 2023 Aug 9;13:1154554. doi: 10.3389/fonc.2023.1154554. eCollection 2023. Front Oncol. 2023. PMID: 37621676 Free PMC article.
Spatial Attention-Based Deep Learning System for Breast Cancer Pathological Complete Response Prediction with Serial Histopathology Images in Multiple Stains.
Duanmu H, Bhattarai S, Li H, Cheng CC, Wang F, Teodoro G, Janssen EAM, Gogineni K, Subhedar P, Aneja R, Kong J. Duanmu H, et al. Among authors: gogineni k. Med Image Comput Comput Assist Interv. 2021 Sep-Oct;12908:550-560. doi: 10.1007/978-3-030-87237-3_53. Epub 2021 Sep 21. Med Image Comput Comput Assist Interv. 2021. PMID: 36222817 Free PMC article.
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
Wu R, Gogineni K, Meisel J, Szabo S, Thirunavu M, Friend S, Bercu Z, Sethi I, Natarajan N, Switchenko J, Levy J, Abdalla E, Weakland L, Kalinsky K, Kokabi N. Wu R, et al. Among authors: gogineni k. Cardiovasc Intervent Radiol. 2022 Nov;45(11):1725-1734. doi: 10.1007/s00270-022-03254-4. Epub 2022 Aug 25. Cardiovasc Intervent Radiol. 2022. PMID: 36008574
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
45 results